149062-75-9 Usage
Class
Quinazoline derivative
Dichloro (Cl2)
Two chlorine atoms attached to the molecule
Hexahydro (C6H12)
Six hydrogen atoms attached to a carbon ring
Azepino
Seven-membered nitrogen-containing ring fused to the quinazoline
Structure
A fused ring system consisting of a quinazoline core with a seven-membered nitrogen-containing ring (azepino) attached
Potential Applications
Pharmaceutical industry
Antipsychotic agent
Potential use in treating psychiatric disorders
Research Status
Further research needed to fully understand potential uses and effects
Solubility
Enhanced solubility due to the hydrochloride salt form
Stability
Improved stability due to the hydrochloride salt form
Molecular Weight
Approximately 360.25 g/mol (with hydrochloride)
Appearance
Likely a solid, possibly crystalline, due to the nature of similar compounds
Polarity
Polar, due to the presence of chlorine atoms and the nitrogen-containing ring system
Reactivity
May react with nucleophiles or other reagents capable of reacting with electrophilic centers or functional groups present in the molecule
Check Digit Verification of cas no
The CAS Registry Mumber 149062-75-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,0,6 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 149062-75:
(8*1)+(7*4)+(6*9)+(5*0)+(4*6)+(3*2)+(2*7)+(1*5)=139
139 % 10 = 9
So 149062-75-9 is a valid CAS Registry Number.
149062-75-9Relevant academic research and scientific papers
QUINAZOLINE DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS
-
, (2008/06/13)
A method of treating cognitive deficiencies is described by administering a quinazoline derivative of the general formula wherein A represents in which n is 1-10, P is a bond or (CH2)m in which m is 0-10, and M is =0 , =S , =NR, =CRR, novel compounds of the above are also described as well as methods of manufacture and pharmaceutical compositions.
